Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Be Biotechnologies logo — Innovating health with groundbreaking plant-based biopharmac...

Be Biotechnologies

Innovating health with groundbreaking plant-based biopharmaceuticals, powered by AI for a modern era of medical solutions.

Founded 2021 Biotechnology, Life Sciences +1

General Information

Company Name Be Biotechnologies
Founded Year 2021
Industries Biotechnology, Life Sciences, Pharmaceutical
Social

Get notified when Be Biotechnologies moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Be Biotechnologies

Be Biotechnologies is a biopharmaceutical company harnessing the potential of plant-based research, development, and evidence-based drug development (EBD), powered by AI. The company's focus is to translate biopharmaceutical sciences into innovative pharmaceutical drugs for human and animal health. With a decentralized Cloud Lab for R&D, the company aims to increase experimental output, replicate past work, and perform deeper analysis seamlessly. Utilizing Artificial Intelligence, every new drug candidate undergoes thorough evaluation by a Board of Curators and Biomedical experts, prioritizing intellectual contributions over manual tasks. Be Biotechnologies' diverse range of plant-based drug candidates addresses unmet medical needs in dermatology, provides antioxidant boosters for astronauts, and offers treatments for chronic pain and various neurological diseases. Moreover, the company has developed over 20 formulations for commercial products, including cosmetics, wellness items, and pharmaceuticals, engaging in the global distribution of APIs/raw materials. As a forward-looking company, Be Biotechnologies aspires to be a hub for microgravity plant science in space, collaborating with NASA and ESA Implementation Partners to enhance the understanding of protein structures. Furthermore, the company is involved in promoting phyto-pharmaceutical treatments pending regulatory clearance, aiming to deliver affordable and modern healthcare solutions.

Be Biotechnologies is an emerging player, offering a unique proposition in the intersection of biotechnology, pharmaceuticals, and AI-driven drug development. With its innovative approach and potential global impact, Be Biotechnologies presents an intriguing opportunity for venture capital investment.

Taxonomy: Biopharmaceuticals, Plant-based research, Cannabinoids, Evidence-based drug development, R&D collaboration, Cloud Lab, Dermatology treatments, Neurological disease treatments, Regulatory clearance, Cosmetics formulations, Wellness products, Pharmaceutical distribution, Space science collaboration, Microgravity research

No funding data available for Be Biotechnologies yet.

Get notified when Be Biotechnologies raises funding

Be Biotechnologies Alternatives & Competitors

Be Biotechnologies vs
Tetra Bio-Pharma
Tetra Bio-Pharma Canada

Tetra Bio-Pharma (TSX: TBP) (OTC-Pink: TBPMF) (FRA: JAM1) is a biopharmaceutical leader in cannabino...

Post Ipo Debt
5 employees
Biopharma, Biotechnology
Be Biotechnologies vs
ONCOCROSS Co., Ltd.
ONCOCROSS Co., Ltd. Korea South

AI, drug discovery development, biotechnology, indication expansion, rare disease, intractable disea...

Corporate Round
18 employees
Biotechnology, Pharmaceutical
Be Biotechnologies vs
GB Sciences, Inc
GB Sciences, Inc United States

AI-Powered Drug Discovery of Plant-Inspired Biopharma Products for the Rx Drug Market

Post Ipo Equity
19 employees
Biotechnology, Health Care

FAQ About Be Biotechnologies

Innovating health with groundbreaking plant-based biopharmaceuticals, powered by AI for a modern era of medical solutions.
Be Biotechnologies was founded in 2021.
Be Biotechnologies operates in the following industries: Biotechnology, Life Sciences, Pharmaceutical.
Top alternatives and competitors to Be Biotechnologies include Tetra Bio-Pharma , ONCOCROSS Co., Ltd., GB Sciences, Inc, Apidel, Valerius Biopharma AG. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Be Biotechnologies and Tetra Bio-Pharma are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Be Biotechnologies and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy